Home Journals Articles Updates About
CN
image
收藏切换
Analysis of influencing factors of steady-state concentration/dose ratio of milnacipran based on therapeutic drug monitoring
收藏切换
PDF
Xiao-qian LAN1, 2, Hong-yan ZHUANG1, 2, Shuang BAO1, 2, Yan-nan ZANG1, 2, Fei JIA1, 2, Meng-xi NIU1, 2, Peng-fei LI1, 2
Chinese Journal of Clinical Pharmacology | 2026, 42(9) : 1216 - 1220
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2026, 42(9): 1216-1220
• Clinical and Basic Bridging Research •
Analysis of influencing factors of steady-state concentration/dose ratio of milnacipran based on therapeutic drug monitoring
Full
Xiao-qian LAN1, 2, Hong-yan ZHUANG1, 2, Shuang BAO1, 2, Yan-nan ZANG1, 2, Fei JIA1, 2, Meng-xi NIU1, 2, Peng-fei LI1, 2
Affiliations
  • 1.Beijing Key Laboratory of Intelligent Drug Research and Development for Mental Disorders/National Clinical Research Center for Mental Disorders/National Center for Mental Disorders, Beijing Anding Hospital Afflicated to Capital Medical University, Beijing 100088, China
  • 2.Beijing Key Laboratory of Critical Bridging Technologies for Chronic Disease Drug Development, Beijing 100029, China
Published: 2026-05-17 doi: 10.13699/j.cnki.1001-6821.2026.09.003
Outline
收藏切换
Objective

To investigate the influencing factors of the steady-state concentration/dose ratio (C/D) for milnacipran tablets based on therapeutic drug monitoring (TDM), with the goal of promoting individualized use of this medication.

Methods

Inpatients who underwent milnacipran TDM were included in this study. General information, including gender, age, body mass index (BMI) and serum creatinine levels were collected through the medical record system. Additionally, dosage and comedication data were recorded. The analysis of these data was conducted using SPSS 23.0.

Results

A total of 156 patients with steady-state concentrations determined by milnacipran TDM were included in the analysis. The steady-state concentration of milnacipran was found to be 95.52 (67.34, 126.97) ng·mL-1, C/D was 0.95 (0.71, 1.24) ng·mL-1·mg-1·d. Multiple linear regression analysis indicated that renal function statistically significantly influenced C/D (P<0.05). C/D ratio in patients with renal insufficiency and patients with normal insufficiency were 1.16 (0.79,1.50) and 0.92 (0.64,1.08) ng·mL-1·mg-1·d, with statisticaly significant difference (P<0.05).

Conclusion

The factors influencing milnacipran’s C/D are complex; therefore, for patients with renal insufficiency, regular monitoring of serum drug concentrations is recommended to ensure both safety and efficacy in its use.

milnacipran tablet  /  therapeutic drug monitoring  /  steady-state concentration  /  influencing factor  /  individualized medicine
Xiao-qian LAN, Hong-yan ZHUANG, Shuang BAO, Yan-nan ZANG, Fei JIA, Meng-xi NIU, Peng-fei LI. Analysis of influencing factors of steady-state concentration/dose ratio of milnacipran based on therapeutic drug monitoring[J]. Chinese Journal of Clinical Pharmacology, 2026 , 42 (9) : 1216 -1220 . DOI: 10.13699/j.cnki.1001-6821.2026.09.003
Appendix
Less
Year 2026 volume 42 Issue 9
PDF
164
29
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2026.09.003
  • Receive Date：2026-03-12
  • Online Date：2026-08-06
  • Published：2026-05-17
Article Data
Affiliations
History
  • Received：2026-03-12
Funding
Affiliations
    1.Beijing Key Laboratory of Intelligent Drug Research and Development for Mental Disorders/National Clinical Research Center for Mental Disorders/National Center for Mental Disorders, Beijing Anding Hospital Afflicated to Capital Medical University, Beijing 100088, China
    2.Beijing Key Laboratory of Critical Bridging Technologies for Chronic Disease Drug Development, Beijing 100029, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2026.09.003
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House